MedPath

Individually tailored elastic compression therapy after deep venous thrombosis in relation to the incidence of post thrombotic syndrome, a randomized multicenter trial

Recruiting
Conditions
post phlebetic syndrome
10064477
10014523
Registration Number
NL-OMON38265
Lead Sponsor
interne geneeskunde laboratorium hematologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
864
Inclusion Criteria

All adult, consenting, consecutive outpatients with acute objectively documented proximal DVT of the leg
•All patients should be treated with a minimum of 5 days of Low Molecular Weight Heparins (LMWH) followed by oral anticoagulants with a target international normalized ratio (INR) of 2-3

Exclusion Criteria

Previous DVT in the affected leg
•Recurrent DVT in the 6 months following inclusion
•Pre-existent venous insufficiency (skin signs C3-C6 on CEAP score or requiring ECS therapy)
•Contraindication for elastic compression therapy (e.g. arterial insufficiency)
•Active thrombolysis
•Life expectancy < 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath